A Systematic Review of the Neurocognitive Effects of Cannabis Use in Older Adults
- 22 October 2019
- journal article
- review article
- Published by Springer Nature in Current Addiction Reports
- Vol. 6 (4) , 443-455
Abstract
Purpose of Review Older adults currently represent the fastest growing demographic of cannabis users, yet few studies have investigated the effects of cannabis use on cognitive functioning in aging. We conducted a systematic review of the recent literature examining cognitive outcomes associated with cannabis use in older adults, with and without neurocognitive disorders, to clarify the potential neuroprotective benefits or risks of cognitive decline in this population. Recent Findings We identified 26 studies examining cognitive outcomes associated with medical and recreational use of cannabis in healthy aging, dementia, Parkinson’s disease, multiple sclerosis, HIV, and pain populations. Although variability in the cannabis products used, outcomes assessed, and study quality limits the conclusions that can be made, modest reductions in cognitive performance were generally detected with higher doses and heavier lifetime use. Summary This review highlights the need for additional high-quality research using standardized, validated assessments of cannabis exposure and cognitive outcomes. Reliable measures and longitudinal data are necessary to better characterize the effects of cannabis use on cognitive aging, as well as differential effects of recreational and medical cannabis.Keywords
This publication has 71 references indexed in Scilit:
- Effects of Cannabis on Neurocognitive Functioning: Recent Advances, Neurodevelopmental Influences, and Sex DifferencesNeuropsychology Review, 2012
- Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 miceJournal of Neuroinflammation, 2012
- Dementia incidence continues to increase with age in the oldest old: The 90+ studyAnnals of Neurology, 2010
- Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort studyLipids in Health and Disease, 2009
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 yearsMovement Disorders, 2008
- Dementia and survival in Parkinson diseaseNeurology, 2008
- Memory complaints in healthy young and elderly adults: Reliability of memory reportingAging & Mental Health, 2008
- Subjective Memory Complaints and Cognitive Impairment in Older PeopleDementia and Geriatric Cognitive Disorders, 2006
- Projecting Drug Use Among Aging Baby Boomers in 2020Annals of Epidemiology, 2006
- Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial ActivationJournal of Neuroscience, 2005